Navigation Links
Beta blockers and perioperative care: EHJ editorial addresses controversy

Zurich, 7 February 2014. Since the end of 2011 when the scientific work of Professor Don Poldermans was first scrutinized there has been controversy in the medical world about the use of beta blockers in perioperative care.

The recent publication - and retraction for proper peer reviewing and revision - in the European Heart Journal (EHJ) of a paper by Professors Cole and Francis from Imperial College, questioning whether beta blockers in perioperative care could lead to a mortality increase brought the topic back into the public eye.

The EHJ has published an editorial (1) today addressing these questions.

In the editorial, Professors Thomas Lscher, Bernard Gersh, Ulf Landmesser and Frank Ruschitzka highlight, among other points, that

  • The meta analysis is mainly driven by the POISE trial that used very high dosages of metoprolol immediately before surgery

  • Different dosing and starting time of betablockade before surgery may importantly determine outcome

  • A registry published in 2013 in JAMA (2) supports the use of perioperative blockade, at least in non-vascular surgery

  • Until today, only one of Prof Poldermans' manuscripts has been retracted, so the validity of his large beta blocker DECREASE trial published in the NEJM remains uncertain (3)

  • A proper clinical trial is needed in order to assess whether the use of beta blockers starting at a low dose several days before surgery - as has been recommended by the ESC Guidelines of 2007 - might be beneficial or harmful

  • The ESC Task Force led by Professors Steen Dalby Kristensen and Juhani Knuuti, is carefully revising all existing evidence and will present a new version of the ESC Guidelines on "Pre-operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery" by this summer. These will try to answer two major issues: 1 Should beta blockers be continued in patients scheduled for surgery who are already on them? 2 Should beta blockers be started in patient undergoing surgery who have never received them previously?

Whether beta blockers in perioperative care are protective, safe or harmful continues to be a subject of debate. The new ESC Guidelines will try to clarify some of the controversial issues. As stated jointly by ACC/AHA/ESC (4), in the meantime, the current position is that "the initiation of beta blockers in patients who will undergo non-cardiac surgery should not be considered routine, but should be considered carefully by each patient's treating physician on a case-by-case basis."


Contact: Céline Colas
European Society of Cardiology

Related medicine news :

1. Lung cancer patients live longer if they use beta-blockers while receiving radiotherapy
2. The Future of Perioperative Medicine – Education for Business Managers in Operating Rooms
3. UC Irvine Health Appoints William C. Wilson, MD, as Hospital Director of Critical Care Services, Division of the Department of Anesthesiology & Perioperative Care
4. UC Irvine’s ‘Perioperative Surgical Home’ Improves Clinical Outcomes While Reducing Healthcare Costs
5. Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC
6. Energy Infusion Meets Skin Care: Introducing Dahryn Silver Gel™
7. Minorities Less Likely to Use Hospice Care: Study
8. Home Elder Care: Buyer, Beware
9. Cost Keeps Many Americans From Good Dental Care: Report
10. The cost of glaucoma care: Small group of patients accounts for large part of costs, study finds
11. Medicare: Barrier to hospice increases hospitalization
Post Your Comments:
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
(Date:11/24/2015)... Los Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... author explored the different restrictions and variables that determine which patients are or are ... are those patients that have a BMI over 40, are more than 100 pounds ...
(Date:11/24/2015)... ... , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls ... meet the device regulations. , Come up short in an inspection and the FDA ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... In response ... growing epidemic as deaths from prescription opioids in the United States grew 400 percent ... In 2013 alone, opioids were involved in 37 percent of all fatal drug overdoses. ...
(Date:11/24/2015)... AL (PRWEB) , ... November 24, 2015 , ... American ... announced today the opening of a holiday pop-up clinic located in Metro Atlanta’s North ... needs in a new and different way. The location is scheduled to operate through ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... WuXi PharmaTech (Cayman) Inc. ("WuXi" or the ... capability and technology platform company serving the pharmaceutical, biotechnology, ... China and the United States ... meeting of shareholders held today, the Company,s shareholders voted ... the previously announced agreement and plan of merger (the ...
(Date:11/24/2015)... , Nov. 24, 2015  In the pharmaceutical ... in an effort to quickly uncover new insights, tactics ... --> --> However, organizations ... market research project and ensure that all rules and ... industry standards. Another major barrier to efficiently launching market ...
(Date:11/24/2015)... Nov. 24, 2015  DILON Diagnostics and GE Healthcare ... agreement for DILON to distribute GE,s Discovery NM750b Molecular ... signing of this distribution agreement will provide Dilon,s experienced ... Imaging system and is considered an initial step in ... solutions for clinicians and their patients. ...
Breaking Medicine Technology: